Benzinga's Top Upgrades, Downgrades For October 27, 2017

Loading...
Loading...

Top Upgrades

  • Raymond James upgraded Amazon.com, Inc. AMZN from Market Perform to Outperform. Amazon shares rose 7.46 percent to $1,045.00 in pre-market trading.
  • Stifel Nicolaus upgraded Quintiles IMS Holdings Inc Q from Hold to Buy. Quintiles IMS shares gained 3.94 percent to close at $105.50 on Thursday.
  • Needham upgraded First Solar, Inc. FSLR from Hold to Buy. First Solar shares rose 9.18 percent to $52.32 in pre-market trading.
  • Compass Point upgraded Radian Group Inc RDN from Neutral to Buy. Radian shares rose 3.01 percent to close at $20.90 on Thursday.
  • JP Morgan upgraded Imax Corp (USA) IMAX from Neutral to Overweight. Imax shares rose 2.35 percent to $23.95 in pre-market trading.
  • Monness Crespi Hardt upgraded Facebook Inc FB from Neutral to Buy. Facebook shares gained 2.05 percent to $174.13 in pre-market trading.
  • Evercore ISI Group upgraded Corporate Office Properties Trust OFC from Underperform to In-Line. Corporate Office Properties shares slipped 0.03 percent to close at $31.15 on Thursday.
  • Analysts at Morgan Stanley upgraded Celgene Corporation CELG from Underweight to Equal-Weight. Celgene shares gained 0.23 percent to $100.22 in pre-market trading.
  • Analysts at Raymond James upgraded Cullen/Frost Bankers, Inc. CFR from Underperform to Market Perform. Cullen/Frost Bankers shares gained 0.95 percent to close at $100.47 on Thursday.


Top Downgrades

  • Analysts at William Blair downgraded Electronics For Imaging, Inc. EFII from Outperform to Market Perform. Electronics for Imaging shares fell 22.86 percent to $32.50 in pre-market trading.
  • SunTrust Robinson Humphrey downgraded Dynegy Inc. DYN from Buy to Hold. Dynegy shares rose 0.72 percent to $11.26 in pre-market trading.
  • JP Morgan downgraded Cerner Corporation CERN from Overweight to Neutral. Cerner shares fell 8.30 percent to $65.40 in pre-market trading.
  • Evercore ISI Group downgraded Tesla Inc TSLA from Outperform to In-Line. Tesla shares declined 1.31 percent to $321.90 in pre-market trading.
  • Analysts at Piper Jaffray downgraded Michaels Companies Inc MIK from Neutral to Underweight. Michaels Companies shares rose 0.48 percent to close at $21.13 on Thursday.
  • Stifel Nicolaus downgraded Gigamon Inc GIMO from Buy to Hold. Gigamon shares gained 6.09 percent to $38.35 in pre-market trading.
  • Evercore ISI Group downgraded Teradyne, Inc. TER from Outperform to In-Line. Teradyne shares gained 7.44 percent to close at $42.03 on Thursday.
  • Credit Suisse downgraded Mercer International Inc. MERC from Outperform to Neutral. Mercer shares fell 0.35 percent to $14.05 in pre-market trading.
  • Mizuho downgraded Dunkin Brands Group Inc DNKN from Neutral to Underperform. Dunkin Brands shares rose 0.43 percent to close at $55.63 on Thursday.
  • Morgan Stanley downgraded Ingersoll-Rand PLC IR from Overweight to Equal-Weight. Ingersoll-Rand shares fell 0.72 percent to close at $90.66 on Thursday.


Top Initiations

  • Canaccord Genuity initiated coverage on Biogen Inc BIIB with a Hold rating. The price target for Biogen is set to $340. Biogen shares closed at $307.64 on Thursday.
  • Wells Fargo initiated coverage on Black Hills Corp BKH with a Market Perform rating. The price target for Black Hills is set to $58. Black Hills shares closed at $65.09 on Thursday.
  • Canaccord Genuity initiated coverage on Voyager Therapeutics Inc VYGR with a Buy rating. The price target for Voyager Therapeutics is set to $35. Voyager Therapeutics shares closed at $21.54 on Thursday.
  • Analysts at SunTrust Robinson Humphrey initiated coverage on Okta Inc OKTA with a Buy rating. The price target for Okta is set to $36. Okta shares closed at $27.59 on Thursday.
  • Analysts at Compass Point initiated coverage of Granite Point Mortgage Trust Inc GPMT with a Buy rating. The price target for Granite Point Mortgage is set to $19.50. Granite Point Mortgage shares closed at $18.13 on Thursday.
  • Analysts at Canaccord Genuity initiated coverage on Alder Biopharmaceuticals Inc ALDR with a Buy rating. The price target for Alder Biopharmaceuticals is set to $20. Alder Biopharmaceuticals shares closed at $10.35 on Thursday.
  • Analysts at Mizuho initiated coverage on CalAtlantic Group Inc CAA with a Buy rating. The price target for CalAtlantic is set to $45. CalAtlantic shares closed at $39.98 on Thursday.
Loading...
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsDowngradesInitiationstop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...